The ability of liposomes to target hepatocellular carcinoma cells in vitro and in vivo and the anti-tumor effect showed a trend in LPs < Gal-LPs < Gal-Mor-LPs, indicating that dual targeting nano-carriers could improve the tumor suppressive effect of CUR. Here, GAL is linked to hepatocellular carcinoma.